Tomlins SA - Search Results

1

Assessment of long-term outcomes associated with urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion at repeat biopsy.

Merdan S, Tomlins SA, Barnett CL, Morgan TM, Montie JE, Wei JT, Denton BT. Merdan S, et al. Among authors: tomlins sa. Cancer. 2015 Nov 15;121(22):4071-9. doi: 10.1002/cncr.29611. Epub 2015 Aug 17. Cancer. 2015. PMID: 26280815 Free PMC article.

2

Elevated alpha-methylacyl-CoA racemase enzymatic activity in prostate cancer.

Kumar-Sinha C, Shah RB, Laxman B, Tomlins SA, Harwood J, Schmitz W, Conzelmann E, Sanda MG, Wei JT, Rubin MA, Chinnaiyan AM. Kumar-Sinha C, et al. Among authors: tomlins sa. Am J Pathol. 2004 Mar;164(3):787-93. doi: 10.1016/s0002-9440(10)63167-7. Am J Pathol. 2004. PMID: 14982833 Free PMC article.

3

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA, Chinnaiyan AM. Tomlins SA, et al. Science. 2005 Oct 28;310(5748):644-8. doi: 10.1126/science.1117679. Science. 2005. PMID: 16254181

4

Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression.

Varambally S, Yu J, Laxman B, Rhodes DR, Mehra R, Tomlins SA, Shah RB, Chandran U, Monzon FA, Becich MJ, Wei JT, Pienta KJ, Ghosh D, Rubin MA, Chinnaiyan AM. Varambally S, et al. Among authors: tomlins sa. Cancer Cell. 2005 Nov;8(5):393-406. doi: 10.1016/j.ccr.2005.10.001. Cancer Cell. 2005. PMID: 16286247 Free article.

5

TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer.

Tomlins SA, Mehra R, Rhodes DR, Smith LR, Roulston D, Helgeson BE, Cao X, Wei JT, Rubin MA, Shah RB, Chinnaiyan AM. Tomlins SA, et al. Cancer Res. 2006 Apr 1;66(7):3396-400. doi: 10.1158/0008-5472.CAN-06-0168. Cancer Res. 2006. PMID: 16585160

6

Of mice and men: cancer gene discovery using comparative oncogenomics.

Tomlins SA, Chinnaiyan AM. Tomlins SA, et al. Cancer Cell. 2006 Jul;10(1):2-4. doi: 10.1016/j.ccr.2006.06.013. Cancer Cell. 2006. PMID: 16843259 Free article.

7

TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer.

Perner S, Demichelis F, Beroukhim R, Schmidt FH, Mosquera JM, Setlur S, Tchinda J, Tomlins SA, Hofer MD, Pienta KG, Kuefer R, Vessella R, Sun XW, Meyerson M, Lee C, Sellers WR, Chinnaiyan AM, Rubin MA. Perner S, et al. Among authors: tomlins sa. Cancer Res. 2006 Sep 1;66(17):8337-41. doi: 10.1158/0008-5472.CAN-06-1482. Cancer Res. 2006. PMID: 16951139

8

Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer.

Laxman B, Tomlins SA, Mehra R, Morris DS, Wang L, Helgeson BE, Shah RB, Rubin MA, Wei JT, Chinnaiyan AM. Laxman B, et al. Among authors: tomlins sa. Neoplasia. 2006 Oct;8(10):885-8. doi: 10.1593/neo.06625. Neoplasia. 2006. PMID: 17059688 Free PMC article.

9

Molecular markers of prostate cancer.

Bradford TJ, Tomlins SA, Wang X, Chinnaiyan AM. Bradford TJ, et al. Among authors: tomlins sa. Urol Oncol. 2006 Nov-Dec;24(6):538-51. doi: 10.1016/j.urolonc.2006.07.004. Urol Oncol. 2006. PMID: 17138135 Review.

10

Integrative molecular concept modeling of prostate cancer progression.

Tomlins SA, Mehra R, Rhodes DR, Cao X, Wang L, Dhanasekaran SM, Kalyana-Sundaram S, Wei JT, Rubin MA, Pienta KJ, Shah RB, Chinnaiyan AM. Tomlins SA, et al. Nat Genet. 2007 Jan;39(1):41-51. doi: 10.1038/ng1935. Epub 2006 Dec 17. Nat Genet. 2007. PMID: 17173048

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

264 results

Search Page